155 related articles for article (PubMed ID: 33093451)
1. TIMELESS regulates sphingolipid metabolism and tumor cell growth through Sp1/ACER2/S1P axis in ER-positive breast cancer.
Zhang S; Huang P; Dai H; Li Q; Hu L; Peng J; Jiang S; Xu Y; Wu Z; Nie H; Zhang Z; Yin W; Zhang X; Lu J
Cell Death Dis; 2020 Oct; 11(10):892. PubMed ID: 33093451
[TBL] [Abstract][Full Text] [Related]
2. Maternal and fetal alkaline ceramidase 2 is required for placental vascular integrity in mice.
Li F; Xu R; Lin CL; Low BE; Cai L; Li S; Ji P; Huang L; Wiles MV; Hannun YA; Obeid LM; Chen Y; Mao C
FASEB J; 2020 Nov; 34(11):15252-15268. PubMed ID: 32959379
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor p53 links ceramide metabolism to DNA damage response through alkaline ceramidase 2.
Xu R; Garcia-Barros M; Wen S; Li F; Lin CL; Hannun YA; Obeid LM; Mao C
Cell Death Differ; 2018 May; 25(5):841-856. PubMed ID: 29229990
[TBL] [Abstract][Full Text] [Related]
4. TIMELESS contributes to the progression of breast cancer through activation of MYC.
Chi L; Zou Y; Qin L; Ma W; Hao Y; Tang Y; Luo R; Wu Z
Breast Cancer Res; 2017 May; 19(1):53. PubMed ID: 28464854
[TBL] [Abstract][Full Text] [Related]
5. Human alkaline ceramidase 2 promotes the growth, invasion, and migration of hepatocellular carcinoma cells via sphingomyelin phosphodiesterase acid-like 3B.
Liu B; Xiao J; Dong M; Qiu Z; Jin J
Cancer Sci; 2020 Jul; 111(7):2259-2274. PubMed ID: 32391585
[TBL] [Abstract][Full Text] [Related]
6. miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.
Tian X; Zhang Z
IUBMB Life; 2018 Jan; 70(1):71-80. PubMed ID: 29247596
[TBL] [Abstract][Full Text] [Related]
7. Alkaline ceramidase 2 is essential for the homeostasis of plasma sphingoid bases and their phosphates.
Li F; Xu R; Low BE; Lin CL; Garcia-Barros M; Schrandt J; Mileva I; Snider A; Luo CK; Jiang XC; Li MS; Hannun YA; Obeid LM; Wiles MV; Mao C
FASEB J; 2018 Jun; 32(6):3058-3069. PubMed ID: 29401619
[TBL] [Abstract][Full Text] [Related]
8. Expansion of Sphingosine Kinase and Sphingosine-1-Phosphate Receptor Function in Normal and Cancer Cells: From Membrane Restructuring to Mediation of Estrogen Signaling and Stem Cell Programming.
Sukocheva OA
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29385066
[TBL] [Abstract][Full Text] [Related]
9. Potential cancer-related role of circadian gene TIMELESS suggested by expression profiling and in vitro analyses.
Mao Y; Fu A; Leaderer D; Zheng T; Chen K; Zhu Y
BMC Cancer; 2013 Oct; 13():498. PubMed ID: 24161199
[TBL] [Abstract][Full Text] [Related]
10. Ceramidases, roles in sphingolipid metabolism and in health and disease.
Coant N; Sakamoto W; Mao C; Hannun YA
Adv Biol Regul; 2017 Jan; 63():122-131. PubMed ID: 27771292
[TBL] [Abstract][Full Text] [Related]
11. High levels of sphingolipids in human breast cancer.
Nagahashi M; Tsuchida J; Moro K; Hasegawa M; Tatsuda K; Woelfel IA; Takabe K; Wakai T
J Surg Res; 2016 Aug; 204(2):435-444. PubMed ID: 27565080
[TBL] [Abstract][Full Text] [Related]
12. ABCC1-Exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1, Shortens Survival of Mice and Patients with Breast Cancer.
Yamada A; Nagahashi M; Aoyagi T; Huang WC; Lima S; Hait NC; Maiti A; Kida K; Terracina KP; Miyazaki H; Ishikawa T; Endo I; Waters MR; Qi Q; Yan L; Milstien S; Spiegel S; Takabe K
Mol Cancer Res; 2018 Jun; 16(6):1059-1070. PubMed ID: 29523764
[TBL] [Abstract][Full Text] [Related]
13. KIAA0101 inhibition suppresses cell proliferation and cell cycle progression by promoting the interaction between p53 and Sp1 in breast cancer.
Lv W; Su B; Li Y; Geng C; Chen N
Biochem Biophys Res Commun; 2018 Sep; 503(2):600-606. PubMed ID: 29902451
[TBL] [Abstract][Full Text] [Related]
14. OCT-4: a novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells.
Bhatt S; Stender JD; Joshi S; Wu G; Katzenellenbogen BS
Oncogene; 2016 Nov; 35(44):5722-5734. PubMed ID: 27065334
[TBL] [Abstract][Full Text] [Related]
15. Timeless-Stimulated miR-5188-FOXO1/β-Catenin-c-Jun Feedback Loop Promotes Stemness via Ubiquitination of β-Catenin in Breast Cancer.
Zou Y; Lin X; Bu J; Lin Z; Chen Y; Qiu Y; Mo H; Tang Y; Fang W; Wu Z
Mol Ther; 2020 Jan; 28(1):313-327. PubMed ID: 31604679
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.
Maor S; Mayer D; Yarden RI; Lee AV; Sarfstein R; Werner H; Papa MZ
J Endocrinol; 2006 Dec; 191(3):605-12. PubMed ID: 17170218
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-phosphate and estrogen signaling in breast cancer.
Maczis M; Milstien S; Spiegel S
Adv Biol Regul; 2016 Jan; 60():160-165. PubMed ID: 26601898
[TBL] [Abstract][Full Text] [Related]
18. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory lipid sphingosine-1-phosphate upregulates C-reactive protein via C/EBPβ and potentiates breast cancer progression.
Kim ES; Cha Y; Ham M; Jung J; Kim SG; Hwang S; Kleemann R; Moon A
Oncogene; 2014 Jul; 33(27):3583-93. PubMed ID: 23955082
[TBL] [Abstract][Full Text] [Related]
20. ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.
Griffin NI; Sharma G; Zhao X; Mirza S; Srivastava S; Dave BJ; Aleskandarany M; Rakha E; Mohibi S; Band H; Band V
Breast Cancer Res; 2016 Nov; 18(1):113. PubMed ID: 27852327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
